Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Takeda to Propose Adding Shire Integration as Performance Objective for Execs’ Stock Compensation
June 14, 2019
- Shionogi Snaps Up Osaka Biotech after Hitting Joint Study Goals
June 14, 2019
- Takeda Founding Family Member Presses for Claw-Back Clause
June 13, 2019
- Growth of Japan Pharma Business Counts on Partnership with Foreign Biotechs: IQVIA Director
June 13, 2019
- Rakuten Medical Could File Photoimmunotherapy for Head and Neck Cancer in 2022; COO Says More Indications Eyed
June 12, 2019
- Taiho Sets Up Venture Capital to Spur Innovation in Japan
June 11, 2019
- Novartis’ Xolair Effective in Severe Cedar Pollen Allergy: Japan PIII
June 11, 2019
- JCR to Launch Japan PI/II for Temcell in Neonatal Hypoxic-Ischemic Encephalopathy
June 11, 2019
- Japan Ethical Drug Sales Surge 5.1% in April: Crecon
June 11, 2019
- Japan Ethical Drug Sales Shrivel, but Many Beat Conservative Guidance
June 11, 2019
- Amicus to Enroll PIII Study for Pompe Therapy AT-GAA by Year-End: COO
June 10, 2019
- Napabucasin PIII Colorectal Cancer Trial to Continue: Sumitomo Dainippon
June 10, 2019
- Keytruda Tops Drug Sales Ranking in May: Encise Snapshot
June 10, 2019
- Pfizer Keeps Diverse Portfolio Strategy amid Sluggish Bavencio, Oncology Chief Says I/O Just One Area of Cancer Care
June 10, 2019
- Oral MDS Treatment ASTX727 Equivalent to IV Dacogen in PIII Study: Otsuka
June 10, 2019
- Taiho to Commercialize Otsuka US Subsidiary’s 2 Cancer Drugs in North America
June 10, 2019
- Konica Minolta Joins Hands with Univ. of Tokyo, NCC on Genetic Profiling
June 7, 2019
- Royalties Push Up Profits at 3 Major Makers, Shionogi Sees 40% Operating Margin This Year
June 7, 2019
- Boehringer’s Japan Pharma Sales on Course for Recovery; Jardiance, Spiolto Upbeat
June 7, 2019
- Astellas Ties Up with Microsoft to Develop Tool Using “Mixed Reality” to Improve Medication Adherence
June 7, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…